Literature DB >> 25084689

Isolated intracerebral light chain deposition disease: novel imaging and pathologic findings.

John-Paul J Yu1, David M Wilson2, Edward F Chang3, Jennifer Cotter4, Arie Perry4, Anuj Mahindra5, Christine M Glastonbury2.   

Abstract

Light chain deposition disease (LCDD) is a rare clinicopathologic entity first described in 1976 and is characterized by a monoclonal gammopathy resulting in nonamyloid immunoglobulin light chain tissue deposition. Only four cases of intracerebral LCDD have been previously reported, all in the setting of a known plasma cell dyscrasia or in the presence of local mature plasma cells. We present the first case of intracranial LCDD in the absence of a known plasma cell dyscrasia or local mature plasma cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amyloidoma; Light chain deposition disease; MRI; Monoclonal immunoglobulin deposition disease

Mesh:

Substances:

Year:  2014        PMID: 25084689      PMCID: PMC4854295          DOI: 10.1016/j.clinimag.2014.06.015

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  16 in total

Review 1.  Light chain deposition disease: novel biological insights and treatment advances.

Authors:  V H Jimenez-Zepeda
Journal:  Int J Lab Hematol       Date:  2012-04-04       Impact factor: 2.877

2.  A 61-year-old man with instability of gait and right hand clumsiness.

Authors:  Anne Vital; Emmanuel Ellie; Hugues Loiseau
Journal:  Brain Pathol       Date:  2010-01       Impact factor: 6.508

Review 3.  Systemic light chain deposition disease presenting as multiple pulmonary nodules. A case report and review of the literature.

Authors:  C H Kijner; S A Yousem
Journal:  Am J Surg Pathol       Date:  1988-05       Impact factor: 6.394

4.  Primary amyloidoma of the brain: CT and MR presentation.

Authors:  J Lee; G Krol; M Rosenblum
Journal:  AJNR Am J Neuroradiol       Date:  1995-04       Impact factor: 3.825

Review 5.  Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis.

Authors:  Per Westermark; Merrill D Benson; Joel N Buxbaum; Alan S Cohen; Blas Frangione; Shu-Ichi Ikeda; Colin L Masters; Giampaolo Merlini; Maria J Saraiva; Jean D Sipe
Journal:  Amyloid       Date:  2005-03       Impact factor: 7.141

6.  Cerebral amyloidoma mimicking intracranial tumor: a case report.

Authors:  Danny Landau; Nicholas Avgeropoulos; Joe Ma
Journal:  J Med Case Rep       Date:  2010-09-20

Review 7.  Cerebral AL lambda-amyloidoma: clinical and pathomorphological characteristics. Review of the literature and of a patient.

Authors:  Bernhard Fischer; Stefan Palkovic; Christian Rickert; Matthias Weckesser; Hansdetlef Wassmann
Journal:  Amyloid       Date:  2007-03       Impact factor: 7.141

Review 8.  Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment.

Authors:  Morie A Gertz
Journal:  Am J Hematol       Date:  2013-05       Impact factor: 10.047

Review 9.  Pulmonary manifestations of light chain deposition disease.

Authors:  Lisa Rho; Libo Qiu; James A Strauchen; Ronald E Gordon; Alvin S Teirstein
Journal:  Respirology       Date:  2009-07       Impact factor: 6.424

10.  Primary cerebral low-grade B-cell lymphoma, monoclonal immunoglobulin deposition disease, cerebral light chain deposition disease and "aggregoma": an update on classification and diagnosis.

Authors:  Marco Skardelly; Georgios Pantazis; Sotirios Bisdas; Guenther C Feigl; Martin U Schuhmann; Marcos S Tatagiba; Rainer Ritz
Journal:  BMC Neurol       Date:  2013-08-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.